PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34422067-11	2021	Moreover, docetaxel injection increased levels of TNF-alpha and IL-6 in plasma and expressions of phospho-NF-kappaB and phospho-STAT3 in both of lumbar spinal cord and sciatic nerves, while SH003 treatment inhibited those changes.	Docetaxel	10-19	tumor necrosis factor	Mus musculus	50-59	
34422067-12	2021	Taken together, it is worth noting that TNF-alpha and IL-6 in plasma and phospho-NF-kappaB and phospho-STAT3 in spinal cord and sciatic nerves are putative biomarkers of docetaxel-induced peripheral neuropathy (DIPN) in mouse models.	Docetaxel	170-179	tumor necrosis factor	Mus musculus	40-49	
33908449-7	2021	The immune system was significantly activated by docetaxel (DTX)-loaded NPs after SDT treatment due to the enhanced secretion of IFN-gamma, TNF-alpha, IL-2 and IL-6 cytokines and tumor-infiltrating CD4+ and CD8+ T cell contents.	Docetaxel	49-58	tumor necrosis factor	Mus musculus	140-149	
33908449-7	2021	The immune system was significantly activated by docetaxel (DTX)-loaded NPs after SDT treatment due to the enhanced secretion of IFN-gamma, TNF-alpha, IL-2 and IL-6 cytokines and tumor-infiltrating CD4+ and CD8+ T cell contents.	Docetaxel	60-63	tumor necrosis factor	Mus musculus	140-149	
28127258-10	2017	RESULTS: TNF-alpha strengthened the cytotoxicity of docetaxel, 5-FU and cisplatin against breast cancer cells both in vitro and in vivo.	Docetaxel	52-61	tumor necrosis factor	Mus musculus	9-18	
28127258-13	2017	Treatment of TNF-alpha brought more DNA damage after Cs137-irradiation and strengthened G2/M and S phase cell cycle arrest induced by docetaxel and cisplatin respectively.	Docetaxel	134-143	tumor necrosis factor	Mus musculus	13-22	
25431358-10	2015	Docetaxel showed synergism with birinapant +- TNFalpha in vitro.	Docetaxel	0-9	tumor necrosis factor	Mus musculus	46-54